Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Verteporfin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Glioblastoma 2 Breast Neoplasms 2 Pleural Effusion, Malignant 1 Pinealoma 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Neuroectodermal Tumors, Primitive 1 Neoplasms, Neuroepithelial 1 Neoplasm Metastasis 1 Meningioma 1 Melanoma 1 Medulloblastoma 1 Malignant Solid Neoplasm 1 Gliosarcoma 1 Glioma, Subependymal 1 Familial ependymoma 1 Ependymoma 1 Craniopharyngioma 1 Choroid Plexus Neoplasms 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

pembrolizumab 268 Nivolumab 241 Ipilimumab 221 aldesleukin 126 Cyclophosphamide 125 Interleukin-2 92 trametinib 76 dabrafenib 68 Dacarbazine 68 Temozolomide 65 Vemurafenib 64 fludarabine 63 fludarabine phosphate 56 Biopsy 45 Radiosurgery 43 Bevacizumab 40 sargramostim 39 binimetinib 38 incomplete Freund's adjuvant 36 Paclitaxel 35 atezolizumab 34 Cisplatin 34 Radiotherapy 33 encorafenib 32 Magnetic Resonance Spectroscopy 32 Blood Specimen Collection 32 cobimetinib 31 Specimen Handling 31 Introns 31 Carboplatin 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00007969 2013-11-06

Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma

National Cancer Institute (NCI)

Phase 1/2 Completed

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡